| # | Drug | Count |
|---|---|---|
| 0 | LEDIPASVIR AND SOFOSBUVIR | 105 |
| 1 | RIBAVIRIN | 48 |
| 2 | VELPATASVIR AND SOFOSBUVIR | 45 |
| 3 | SOFOSBUVIR | 41 |
| 4 | CLOZAPINE | 39 |
| 5 | GLECAPREVIR AND PIBRENTASVIR | 23 |
| 6 | ETANERCEPT | 22 |
| 7 | TACROLIMUS | 18 |
| 8 | ADALIMUMAB | 17 |
| 9 | OLANZAPINE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 12 | 0.0110 |
| 1 | LEDIPASVIR AND SOFOSBUVIR | 105 | 0.0055 |
| 2 | VELPATASVIR AND SOFOSBUVIR | 45 | 0.0035 |
| 3 | GLECAPREVIR AND PIBRENTASVIR | 23 | 0.0021 |
| 4 | SOFOSBUVIR | 41 | 0.0021 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 3 | 0.0014 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 10 | 0.0012 |
| 7 | ELBASVIR AND GRAZOPREVIR | 5 | 0.0012 |
| 8 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 9 | CLOFAZIMINE | 5 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS5A Inhibitor [EPC] | 189 | 0.0039 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 201 | 0.0038 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 40 | 0.0025 |
| 3 | Nucleoside Analog Antiviral [EPC] | 48 | 0.0006 |
| 4 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 6 | Antimycobacterial [EPC] | 5 | 0.0002 |
| 7 | Oxazolidinone Antibacterial [EPC] | 5 | 0.0002 |
| 8 | Atypical Antipsychotic [EPC] | 47 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |